Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Nonpeptide integrin antagonists from DuPont and use for inhibiting cell adhesion

Oct. 25, 1999

Alphagan safely and effectively lowers IOP in glaucoma patients

Oct. 25, 1999

News from AAO/PAAO joint meeting: droperidol may be indicated for glaucoma

Oct. 25, 1999

Development status update for antiglaucoma drug candidate

Oct. 22, 1999

Verteporfin prevents vision loss in AMD patients with predominantly classic CNV lesions

Oct. 19, 1999

Preclinical results indicate a new target for RP therapy: calcium channel blockade

Oct. 18, 1999

FDA advisory committee to review Visudyne NDA

Oct. 8, 1999

Yale study will evaluate memantine's ability to prevent vision loss in glaucoma patients

Oct. 4, 1999

Liposomal foscarnet derivative is a promising treatment for CMV retinitis

Sep. 28, 1999

FDA approves Santen's Alamast for prevention of itchy eyes due to allergic conjunctivitis

Sep. 27, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...